Results 31 to 40 of about 34,072 (291)

Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China

open access: yesBMC Ophthalmology, 2021
Background To evaluate the 12-month efficacy and safety of intravitreal conbercept for myopic choroidal neovascularization (CNV). Methods A retrospective, observational study.
Xin Nie   +3 more
doaj   +1 more source

Key Multimodal Fundus Imaging Findings to Recognize Multifocal Choroiditis in Patients With Pathological Myopia

open access: yesFrontiers in Medicine, 2022
Myopia represents a major socioeconomic burden with an increasing prevalence worldwide. Pathologic myopia refers to myopic patients with structural changes in the posterior pole including different patterns of chorioretinal atrophy, choroidal ...
Roberto Gallego-Pinazo   +2 more
doaj   +1 more source

Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome [PDF]

open access: yes, 2013
OBJECTIVE: To report the visual outcome after 4-year follow-up in a series of highly myopic eyes with choroidal neovascularisation (CNV) treated with antivascular endothelial growth factor (anti-VEGF) drugs.
Arias, L   +4 more
core   +1 more source

Thymidine phosphorylase and its possible correlation with the lung cancer phenotype features

open access: yesPatologìâ, 2015
The tumor phenotype investigation is necessary for lung cancer drug therapy optimization. For this purpose is perspective to use the biochemical markers of angiogenesis. Thymidine phosphorylase may be one of them. Aim. The aim of study was to evaluate
E. M. Bakurova   +5 more
doaj   +1 more source

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity [PDF]

open access: yesCancer, 1994
Prostate adenocarcinoma is a significant cause of morbidity and mortality in older men. However, the histologic prevalence far exceeds clinically manifest disease. Increased screening has resulted in the detection of a large number of carcinomas of unknown malignant potential.
Steven D. Preston   +4 more
openaire   +3 more sources

Tendinopathy—from basic science to treatment [PDF]

open access: yes, 2008
Chronic tendon pathology (tendinopathy), although common, is difficult to treat. Tendons possess a highly organized fibrillar matrix, consisting of type I collagen and various 'minor' collagens, proteoglycans and glycoproteins.
A McCormick   +69 more
core   +1 more source

Suppression of pathological ocular neovascularization by a small molecule, SU1498

open access: yesBiomedicine & Pharmacotherapy, 2020
Selective inhibition of vascular endothelial growth factor receptor (VEGFR), particularly VEGFR-2, is an efficient method for the treatment of ocular neovascularization. SU1498 is a specific inhibitor of VEGFR-2. In this study, we investigated the role of SU1498 in ocular neovascularization.
Yan Biao   +4 more
openaire   +3 more sources

Multidimensional en-face OCT imaging of the retina. [PDF]

open access: yes, 2009
Fast T-scanning (transverse scanning, en-face) was used to build B-scan or C-scan optical coherence tomography (OCT) images of the retina. Several unique signature patterns of en-face (coronal) are reviewed in conjunction with associated confocal images ...
Adrian G. Podoleanu   +34 more
core   +1 more source

Management of Myopic Maculopathy: A Review

open access: yesTürk Oftalmoloji Dergisi, 2023
Myopia, including pathologic myopia, has seen a significant increase in prevalence in recent years. It is a significant cause of irreversible vision loss worldwide and prediction models demonstrate the substantial future impact on the population.
William J. Anderson, Levent Akduman
doaj   +1 more source

FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice

open access: yesCell Reports, 2017
Pathological neovascularization, a leading cause of blindness, is seen in retinopathy of prematurity, diabetic retinopathy, and age-related macular degeneration.
Zhongjie Fu   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy